- **Revenue and Margin Growth**: 2025 revenue up 1.4% to $346.8M, EBITDA +23% to $68.7M. Q4 EBITDA margin 22% (+160bps YoY). 2026 targets: modest revenue growth, 200bps EBITDA margin expansion.
- **Pipeline and AI Momentum**: $19.8M Q4 bookings (TCV), 53% pipeline growth. AI initiatives reduce documentation time by 50%-75%, with encoder pipeline +74%.
- **Financial Strength**: Free cash flow $20M (2025), net debt $139.8M (2x leverage). New $250M credit facility improves liquidity.
- **Customer Retention and Strategy**: Global workforce transition model improves retention. Strategic review underway to maximize shareholder value.

**【CEO Summary Section】**
- **Strategic Review and Financial Health**: CEO Chris Fowler announced a strategic review process to maximize shareholder value, with a focus on modest 2026 revenue growth and 200 basis points of EBITDA margin expansion. The company achieved $87.2M Q4 revenue (flat YoY, excluding Centriq sunset) and $19.2M adjusted EBITDA (22% margin, +160bps YoY). Full-year revenue grew 1.4% to $346.8M, with EBITDA up 23% to $68.7M.
- **Pipeline and Bookings Momentum**: Q4 bookings of $19.8M (TCV) reflect 53% pipeline growth since Q3, driven by recurring deals (70% of pipeline) and higher-margin encoder solutions (+74% pipeline). Full-year bookings reached $82.9M (TCV), up 1% YoY.
- **Customer Retention and AI Strategy**: Improved retention through a structured transition model and new Global Capacity Center in Chennai. AI initiatives across financial health, patient care, and internal operations aim to enhance efficiency and customer experience, with early pilots showing 50%-75% reduction in documentation time.

**【CFO Financial Commentary】**
- **Cash Flow and Debt Optimization**: Free cash flow of $20M (2025) reflects disciplined capital allocation. Net debt reduced by $19.5M YoY to $139.8M, with a 2x net leverage ratio. A new $250M credit facility extends maturity and lowers cost of capital.
- **Margin Expansion Drivers**: 350bps EBITDA margin expansion in 2025 from cost optimization (IT, cloud, patient care support) and offshore workforce transition. Gross margin improved 120bps QoQ to 53%, with Financial Health gross margin up 65bps.
- **Revenue Mix Shift**: Encoder and SaaS growth (higher margins) offset service-based revenue declines. Patient Care revenue (+4% ex-Centriq) reflects SaaS adoption.

**【Q&A Highlights】**
- **Bookings Conversion and Pipeline Quality**: CFO Vinay Bassi emphasized bookings-to-revenue conversion through attrition modeling. CEO highlighted pipeline diversification (14% to 30% of pipeline from >100-bed hospitals) and improved deal quality (70% recurring revenue).
- **AI and Regulatory Impact**: AI-driven efficiency in claims denial prediction and patient care documentation (50%-75% time reduction) positions TruBridge to capitalize on rural health funding ($50B EHR modernization initiative). Competitive differentiation through Ambient Technology pilots and customer-facing AI chatbots.
- **Strategic Review and Capital Allocation**: No timeline for strategic review resolution. Focus on debt reduction, share buybacks, and high-ROI investments in AI and encoder solutions.

TBRG(Delisted)

TBRG(Delisted)

TruBridge (TBRG) Financials Overview

TBRG Q4 2025 Earnings

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

Income Statement

Trend

Breakdown

Balance Sheet

Trend

Breakdown

Cash Flow

Trend

Breakdown

Revenue Breakdown

By Business

By Region

Dividend

Payout Ratio

Dividend Yield

You can ask Aime